HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.00
+2.50 (6.67%)
Nov 13, 2026, 1:30 PM CST

HeXun Biosciences Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
538.65208.2200.99257.67119.7485.03
Short-Term Investments
242301.431727272-
Cash & Short-Term Investments
845.69509.63372.99329.67191.7485.03
Cash Growth
70.49%36.63%13.14%71.94%125.51%-
Accounts Receivable
76.4274.5684.6822.284.98-
Other Receivables
-0.720.23---
Receivables
76.4275.2884.9122.284.98-
Inventory
17.96.0215.584.6--
Prepaid Expenses
16.499.518.336.859.448.37
Other Current Assets
13.969.181.440.275.080.01
Total Current Assets
970.46609.61483.25363.67211.2493.4
Property, Plant & Equipment
144.19148.22139.1113.9394.27102.83
Other Intangible Assets
16.3220.8826.6734.2641.231.75
Long-Term Deferred Tax Assets
1.31.31.57---
Other Long-Term Assets
69.7257.0756.3459.5757.4196.64
Total Assets
1,202837.07706.92571.43404.15294.62

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8.623.174.242.433.232.81
Accrued Expenses
-24.7413.19.653.211.42
Current Portion of Long-Term Debt
---2.552.350.59
Current Portion of Leases
3.733.953.042.842.132.07
Current Income Taxes Payable
23.5610.7615.65---
Current Unearned Revenue
8.3713.968.71.733.6-
Other Current Liabilities
21.955.979.0310.985.510.93
Total Current Liabilities
66.2362.5453.7630.1720.037.83
Long-Term Debt
---34.937.2639.41
Long-Term Leases
29.8932.6231.9832.3229.932.03
Long-Term Unearned Revenue
----1.5-
Pension & Post-Retirement Benefits
---0.08--
Long-Term Deferred Tax Liabilities
0.30.3----
Other Long-Term Liabilities
--0.60.60.60.6
Total Liabilities
96.4295.4786.3498.0789.2879.87

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
521.34460460460410360
Additional Paid-In Capital
350.56139.41130.3130.355.3-
Retained Earnings
237.81142.1830.28-116.95-150.44-145.25
Shareholders' Equity
1,106741.6620.58473.36314.87214.75
Total Liabilities & Equity
1,202837.07706.92571.43404.15294.62

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
33.6236.5835.0272.6171.6474.1
Net Cash (Debt)
812.07473.05337.97257.06120.1110.93
Net Cash Growth
77.12%39.97%31.47%114.03%999.17%-
Net Cash Per Share
17.0610.287.345.673.200.36
Filing Date Shares Outstanding
51.914646464630.51
Total Common Shares Outstanding
51.914646464130.51
Working Capital
904.23547.06429.49333.5191.2285.58
Book Value Per Share
21.3016.1213.4910.297.687.04
Tangible Book Value
1,089720.71593.91439.09273.64213.01
Tangible Book Value Per Share
20.9815.6712.919.556.676.98
Machinery
-139.67118.9582.4963.5763.23
Leasehold Improvements
-31.929.822821.6920.92